Second primary lung cancer after head and neck squamous cell cancer: population-based study of risk factors.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 22319019.
- Also identified by DOI 10.1002/hed.22006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with head and neck squamous cell cancer (HNSCC) are at risk of developing second primary lung cancer (SPLC). Among 61,883 patients with HNSCC from the Surveillance, Epidemiology and End Results (SEER) database, 4522 developed SPLC (any histology) ≥2 months after HNSCC. We correlated risk with demographic and tumor-related parameters. The risk of SPLC after HNSCC was 5.8%, 11.4%, and 16.4% at 5, 10, and 15 years, respectively. From Cox regression, significantly adverse (p < .0001) risk factors for SPLC included: regional versus localized HNSCC stage (hazard ratio [HR] = 1.16), hypopharyngeal or supraglottic laryngeal site (HR = 1.57), increased age (HR = 1.26/decade), black race (HR = 1.27), and male sex (HR = 1.26). Glottic (HR = 0.75) and tonsillar or oral cavity sites (HR = 0.80) were associated with significantly (p < .0001) lower risks of SPLC. From population-based actuarial analyses, HNSCCs with more aggressive clinicopathologic features were more apt to develop SPLC, suggestive of similar environmental and/or host factors for these cancers.
Medical subject headings
- Carcinoma, Squamous Cell
- Head and Neck Neoplasms
- Lung Neoplasms
- Neoplasms, Second Primary